VERTEX PHARMACEUTICALS INC (1VRTX.MI) Forecast, Price Target & Analyst Ratings

Name: VERTEX PHARMACEUTICALS INC (1VRTX.MI) Analyst Consensus Rating
Brand: VERTEX PHARMACEUTICALS INC
Rating: 7.5 (39 reviews)

BIT:1VRTX • US92532F1003

334.7 EUR

-2.05 (-0.61%)

Last: Sep 10, 2025, 07:00 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERTEX PHARMACEUTICALS INC (1VRTX.MI).

Consensus Price Target

Price Target

€416.50

+ 24.44% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Nov 3, 2025
Period: Q3 / 2025
EPS Estimate: $4.72
Revenue Estimate: 3.116B

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

75.90%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

€416.50

Upside

+ 24.44%

From current price of €334.70 to mean target of €416.50, Based on 39 analyst forecasts

Low

€283.13

Median

€414.16

High

€556.57

Price Target Revisions

1 Month

-5.11%

3 Months

-11.39%

Price Target Summary

39 Wall Street analysts provided a forecast for the next 12 months for 1VRTX.MI. The average price target is 416.5 EUR. This implies a price increase of 24.44% is expected in the next year compared to the current price of 334.7.

The average price target has been revised downward by 11.39% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

75.90%

1VRTX.MI was analyzed by 39 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about 1VRTX.MI.

In the previous month the buy percentage consensus was at a similar level.

1VRTX.MI was analyzed by 39 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date: Nov 3, 2025
Period: Q3 / 2025
EPS Estimate: $4.72
Revenue Estimate: 3.116B
Revenue Q2Q: 12.41%
EPS Q2Q: 7.66%
Number of Analysts: 29

Next Earnings Revisions

Revenue (1 Month)

0.39%

Revenue (3 Months)

1.43%

EPS (1 Month)

0.02%

EPS (3 Months)

1.80%

Next Earnings Summary

1VRTX.MI is expected to report earnings on 11/3/2025. The consensus EPS estimate for the next earnings is 4.72 EUR and the consensus revenue estimate is 3.12B EUR.

The next earnings revenue estimate has been revised upward by 1.43% in the past 3 months.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032
Revenue YoY % growth	8.931B 17.91%	9.869B 10.51%	11.02B 11.66%	12.221B 10.90%	13.391B 9.57%	14.576B 8.85%	16.108B 10.51%	17.898B 11.11%	19.791B 10.58%	20.984B 6.03%	23.078B 9.98%
EBITDA YoY % growth	4.584B 57.66%	4.54B -0.96%	4.603B 1.37%	5.52B 19.93%	6.705B 21.47%	7.408B 10.48%	7.501B 1.26%	8.155B 8.72%	8.866B 8.72%	9.49B 7.04%	11.313B 19.21%
EBIT YoY % growth	4.436B 59.44%	4.359B -1.73%	4.396B 0.84%	5.397B 22.78%	6.327B 17.23%	6.958B 9.97%	7.47B 7.36%	8.428B 12.82%	8.996B 6.74%	9.778B 8.69%	10.875B 11.22%
Operating Margin	49.67%	44.17%	39.89%	44.16%	47.25%	47.74%	46.37%	47.09%	45.46%	46.60%	47.12%
EPS YoY % growth	14.89 14.36%	15.22 2.22%	0.29 -98.09%	18.43 6,256.61%	20.94 13.60%	23.01 9.86%	25.21 9.56%	28.74 14.00%	31.02 7.97%	33.69 8.60%	38.07 13.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q3 / 25	Q4 / 25	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26
EPS Q2Q % growth	4.72 7.66%	5.09 27.82%	5.21 28.38%	5.35 18.34%	5.06 7.21%	4.97 -2.36%
Revenue Q2Q % growth	3.116B 12.41%	3.271B 12.33%	3.204B 15.66%	3.315B 11.82%	3.339B 7.16%	3.378B 3.27%
EBITDA Q2Q % growth	1.423B 10.14%	1.567B 18.65%	1.776B 64.86%	1.698B 35.47%	1.598B 12.30%	1.4B -10.66%
EBIT Q2Q % growth	1.398B 23.57%	1.531B 37.49%	1.586B 54.15%	1.614B 39.95%	1.556B 11.30%	1.48B -3.33%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

329.69%

EPS Next 5 Year

150.73%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

9.48%

Revenue Next 5 Year

10.01%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

130.80%

EBIT Next 5 Year

68.38%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VERTEX PHARMACEUTICALS INC / 1VRTX.MI Forecast FAQ

What do analysts expect the price target to be for VERTEX PHARMACEUTICALS INC (1VRTX.MI)?

39 analysts have analysed 1VRTX.MI and the average price target is 416.5 EUR. This implies a price increase of 24.44% is expected in the next year compared to the current price of 334.7.

What is the next earnings date for 1VRTX stock?

VERTEX PHARMACEUTICALS INC (1VRTX.MI) will report earnings on 2025-11-03, after the market close.

What are the consensus estimates for 1VRTX stock next earnings?

The consensus EPS estimate for the next earnings of VERTEX PHARMACEUTICALS INC (1VRTX.MI) is 4.72 EUR and the consensus revenue estimate is 3.12B EUR.

What is the expected long term growth rate for VERTEX PHARMACEUTICALS INC (1VRTX.MI)?

The expected long term growth rate for VERTEX PHARMACEUTICALS INC (1VRTX.MI) is 9.48%.

Analyst forecast overview

Forecast Snapshot